Evidence map›Paper›PMID 27811911›Full record

ArticleNature communications2016

Rad18-dependent SUMOylation of human specialized DNA polymerase eta is required to prevent under-replicated DNA.

Emmanuelle Despras, Méghane Sittewelle, Caroline Pouvelle, Noémie Delrieu, Agnès M Cordonnier, Patricia L Kannouche

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Impacts of arsenic on Rad18 and translesion synthesis.Toxicology and applied pharmacology · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Emmanuelle DesprasUniv Paris-Sud, Laboratory Genetic stability and Oncogenesis, Equipe Labellisée La Ligue Contre Le Cancer, Villejuif 94805, France.
Méghane SittewelleUniv Paris-Sud, Laboratory Genetic stability and Oncogenesis, Equipe Labellisée La Ligue Contre Le Cancer, Villejuif 94805, France.
Caroline PouvelleUniv Paris-Sud, Laboratory Genetic stability and Oncogenesis, Equipe Labellisée La Ligue Contre Le Cancer, Villejuif 94805, France.
Noémie DelrieuUniv Paris-Sud, Laboratory Genetic stability and Oncogenesis, Equipe Labellisée La Ligue Contre Le Cancer, Villejuif 94805, France.
Agnès M CordonnierCNRS-UMR 7242, Biotechnologie et Signalisation Cellulaire, Université de Strasbourg, Ecole Supérieure de Biotechnologie, Illkirch 67412, France.
Patricia L KannoucheUniv Paris-Sud, Laboratory Genetic stability and Oncogenesis, Equipe Labellisée La Ligue Contre Le Cancer, Villejuif 94805, France.
Institut Gustave Roussy · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Translesion polymerase eta (polη) was characterized for its ability to replicate ultraviolet-induced DNA lesions that stall replicative polymerases, a process promoted by Rad18-dependent PCNA mono-ubiquitination. Recent findings have shown that polη also acts at intrinsically difficult to replicate sequences. However, the molecular mechanisms that regulate its access to these loci remain elusive. Here, we uncover that polη travels with replication forks during unchallenged S phase and this requires its SUMOylation on K163. Abrogation of polη SUMOylation results in replication defects in response to mild replication stress, leading to chromosome fragments in mitosis and damage transmission to daughter cells. Rad18 plays a pivotal role, independently of its ubiquitin ligase activity, acting as a molecular bridge between polη and the PIAS1 SUMO ligase to promote polη SUMOylation. Our results provide the first evidence that SUMOylation represents a new way to target polη to replication forks, independent of the Rad18-mediated PCNA ubiquitination, thereby preventing under-replicated DNA.

Indexed as

DNA ReplicationCell LineDNA-Binding ProteinsDNA-Directed DNA PolymeraseHumansProliferating Cell Nuclear AntigenProtein Inhibitors of Activated STATSmall Ubiquitin-Related Modifier ProteinsS PhaseSumoylationUbiquitin-Protein LigasesY-Family DNA PolymerasesDNA-Binding ProteinsDNA-Directed DNA PolymerasePIAS1 protein, humanProliferating Cell Nuclear AntigenProtein Inhibitors of Activated STATRAD18 protein, humanRad30 proteinSmall Ubiquitin-Related Modifier ProteinsUbiquitin-Protein LigasesY-Family DNA Polymerases

Identifiers

PMID27811911
PMCPMC5097173
OpenAlexW2548312767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.